14-day Premium Trial Subscription Try For FreeTry Free
HK$97.75
+0.350 (+0.359%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days HK$75.45 HK$99.15 Friday, 3rd May 2024 6160.HK stock ended at HK$97.75. This is 0.359% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.07% from a day low at HK$96.20 to a day high of HK$99.15.
90 days HK$75.45 HK$112.10
52 weeks HK$75.45 HK$157.00

Historical BeiGene, Ltd. prices

Date Open High Low Close Volume
May 03, 2024 HK$96.55 HK$99.15 HK$96.20 HK$97.75 678 300
May 02, 2024 HK$94.60 HK$97.90 HK$93.75 HK$97.40 665 729
Apr 30, 2024 HK$94.35 HK$95.95 HK$93.80 HK$94.60 1 359 821
Apr 29, 2024 HK$92.00 HK$96.10 HK$91.75 HK$94.35 1 629 000
Apr 26, 2024 HK$90.30 HK$92.30 HK$90.00 HK$91.95 1 734 600
Apr 25, 2024 HK$86.95 HK$92.35 HK$86.05 HK$90.00 2 635 751
Apr 24, 2024 HK$83.05 HK$87.60 HK$83.05 HK$87.00 1 958 781
Apr 23, 2024 HK$79.60 HK$82.30 HK$79.20 HK$82.00 1 668 071
Apr 22, 2024 HK$77.90 HK$80.30 HK$77.20 HK$79.65 1 349 585
Apr 19, 2024 HK$79.20 HK$79.20 HK$75.45 HK$77.00 1 811 384
Apr 18, 2024 HK$79.95 HK$80.50 HK$78.70 HK$79.20 1 102 180
Apr 17, 2024 HK$81.45 HK$81.95 HK$79.15 HK$81.05 1 127 173
Apr 16, 2024 HK$82.50 HK$83.85 HK$81.50 HK$82.10 1 008 363
Apr 15, 2024 HK$85.75 HK$86.25 HK$82.75 HK$84.00 1 046 800
Apr 12, 2024 HK$88.00 HK$89.00 HK$85.50 HK$85.70 793 622
Apr 11, 2024 HK$90.60 HK$90.60 HK$88.25 HK$88.55 1 073 700
Apr 10, 2024 HK$92.10 HK$93.65 HK$91.55 HK$93.20 729 496
Apr 09, 2024 HK$90.05 HK$91.80 HK$89.00 HK$91.40 891 005
Apr 08, 2024 HK$91.00 HK$91.85 HK$89.55 HK$90.05 760 372
Apr 05, 2024 HK$92.60 HK$92.60 HK$89.25 HK$90.70 365 408
Apr 03, 2024 HK$93.00 HK$93.05 HK$90.60 HK$92.60 1 124 298
Apr 02, 2024 HK$94.80 HK$95.15 HK$91.70 HK$93.85 1 028 481
Mar 28, 2024 HK$92.65 HK$96.30 HK$91.95 HK$95.10 1 366 545
Mar 27, 2024 HK$92.20 HK$93.60 HK$91.85 HK$92.65 898 183
Mar 26, 2024 HK$91.90 HK$94.20 HK$91.60 HK$93.65 686 458
Click to get the best stock tips daily for free!

About BeiGene, Ltd.

BeiGene Ltd. BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tu... 6160.HK Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT